Alimera Sciences reported $-3115000 in Net Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 924M 3566M
Aerie Pharmaceuticals AERI:US $ -19.37M 16.52M
Alimera Sciences ALIM:US $ -3.12M 2.84M
Applied Genetic Technologies AGTC:US $ -14.29M 4.85M
Bayer BAYN:GR € 3291M 2130M
Insmed INSM:US $ -95645000 1.02M
Novartis NOVN:VX SF 1694M 528M
Ophthotech OPHT:US $ -49.26M 14.73M
Regeneron Pharmaceuticals REGN:US $ 852.1M 121.4M